Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapy

समान संसाधन

• Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy
  द्वारा: Aoyama, Toru, और अन्य
  प्रकाशित: (2017)
• Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine
  द्वारा: Aoyama, Toru, और अन्य
  प्रकाशित: (2017)
• The short- and long-term outcomes of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas
  द्वारा: Murakawa, Masaaki, और अन्य
  प्रकाशित: (2015)
• The impact of SPARC expression on the survival of pancreatic ductal adenocarcinoma patients after curative resection
  द्वारा: Murakawa, Masaaki, और अन्य
  प्रकाशित: (2019)
• Clinical Significance of INHBA Gene Expression in Patients with Gastric Cancer who Receive Curative Resection Followed by Adjuvant S-1 Chemotherapy
  द्वारा: KATAYAMA, YUSUKE, और अन्य
  प्रकाशित: (2017)